GRAY SUSANNAH — SEC insider filings

SEC reporting owner CIK 1833453. 30 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 30 filings on record, filed 2020-11-23 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)Director71 leg · 20,000 sh · $540,000—6
Theravance Biopharma, Inc. (TBPH)Director6——19
Morphic Holding, Inc. (MORF)Director8——11
4D Molecular Therapeutics, Inc. (FDMT)Director6——6
Apria, Inc. (APR)Director2——2
ANAPTYSBIO, INC (ANAB)Director1——1

Insider filings — GRAY SUSANNAH

FiledFormIssuerReported transactionsSource
2026-09-244Theravance Biopharma, Inc. (TBPH)Disposition to issuer (D): 42,137 · Disposition to issuer (D): 6,009 · Disposition to issuer (D): 32,666 (derivative) · Disposition to issuer (D): 22,044 (derivative) · Disposition to issuer (D): 23,576 (derivative) · Disposition to issuer (D): 24,258 (derivative) · +1 moreEDGAR
2026-06-1844D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-164Theravance Biopharma, Inc. (TBPH)Grant/award (A): 6,009 @ $0 · Grant/award (A): 13,398 (derivative) @ $0EDGAR
2026-05-284MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)Grant/award (A): 46,293 @ $0EDGAR
2026-04-294ANAPTYSBIO, INC (ANAB)Grant/award (A): 11,250 (derivative) @ $0EDGAR
2025-06-2044D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2025-06-184MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)Grant/award (A): 89,139 @ $2.16EDGAR
2025-05-214Theravance Biopharma, Inc. (TBPH)Grant/award (A): 10,649 @ $0 · Grant/award (A): 24,258 (derivative) @ $0EDGAR
2024-08-204Morphic Holding, Inc. (MORF)Disposition to issuer (D): 18,111 (derivative) · Disposition to issuer (D): 17,550 (derivative) · Disposition to issuer (D): 12,535 (derivative) · Disposition to issuer (D): 23,168 (derivative)EDGAR
2024-06-054Morphic Holding, Inc. (MORF)Grant/award (A): 23,168 (derivative) @ $0EDGAR
2024-05-244MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)Grant/award (A): 20,645 @ $10.78EDGAR
2024-05-2344D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2024-05-104Theravance Biopharma, Inc. (TBPH)Grant/award (A): 10,537 @ $0 · Grant/award (A): 23,576 (derivative) @ $0EDGAR
2023-07-194MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)Grant/award (A): 24,000 @ $0EDGAR
2023-06-024Morphic Holding, Inc. (MORF)Grant/award (A): 12,535 (derivative) @ $0EDGAR
2023-05-2544D Molecular Therapeutics, Inc. (FMDT)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2023-05-044Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,132 @ $0 · Grant/award (A): 22,044 (derivative) @ $0EDGAR
2023-02-284Theravance Biopharma, Inc. (TBPH)Grant/award (A): 10,131 @ $0 · Grant/award (A): 1,688 @ $0 · Grant/award (A): 28,000 (derivative) @ $0 · Grant/award (A): 4,666 (derivative) @ $0EDGAR
2022-06-104Morphic Holding, Inc. (MORF)Grant/award (A): 17,550 (derivative) @ $0EDGAR
2022-05-2544D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2022-04-294/AMorphic Holding, Inc. (MORF)Grant/award (A): 0 (derivative) @ $0EDGAR
2022-04-294/AMorphic Holding, Inc. (MORF)Grant/award (A): 18,111 (derivative) @ $0EDGAR
2022-03-294Apria, Inc. (APR)Disposition to issuer (D): 5,059 (derivative) @ $37.50EDGAR
2021-11-234MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)Grant/award (A): 4,271 @ $0EDGAR
2021-06-174Morphic Holding, Inc. (MORF)Grant/award (A): 12,000 (derivative) @ $0EDGAR
2021-06-144Apria, Inc. (APR)Grant/award (A): 5,059 (derivative) @ $0EDGAR
2021-05-1944D Molecular Therapeutics Inc. (FDMT)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2021-04-294Morphic Holding, Inc. (MORF)Grant/award (A): 24,000 (derivative) @ $0EDGAR
2020-11-254MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)Purchase (P): 20,000 @ $27EDGAR
2020-11-234MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)Grant/award (A): 11,852 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1833453 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs